000 | 01992 a2200577 4500 | ||
---|---|---|---|
005 | 20250518045713.0 | ||
264 | 0 | _c20191017 | |
008 | 201910s 0 0 eng d | ||
022 | _a1768-3254 | ||
024 | 7 |
_a10.1016/j.ejmech.2019.06.036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBorazjani, Nassim | |
245 | 0 | 0 |
_aThree-component synthesis of chromeno β-lactam hybrids for inflammation and cancer screening. _h[electronic resource] |
260 |
_bEuropean journal of medicinal chemistry _cOct 2019 |
||
300 |
_a389-403 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemical synthesis |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aBenzopyrans _xchemistry |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aRAW 264.7 Cells |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_abeta-Lactams _xchemistry |
700 | 1 | _aSepehri, Saghi | |
700 | 1 | _aBehzadi, Maryam | |
700 | 1 | _aJarrahpour, Aliasghar | |
700 | 1 | _aRad, Javad Ameri | |
700 | 1 | _aSasanipour, Maryam | |
700 | 1 | _aMohkam, Milad | |
700 | 1 | _aGhasemi, Younes | |
700 | 1 | _aAkbarizadeh, Amin Reza | |
700 | 1 | _aDigiorgio, Carole | |
700 | 1 | _aBrunel, Jean Michel | |
700 | 1 | _aGhanbari, Mohammad Mehdi | |
700 | 1 | _aBatta, Gyula | |
700 | 1 | _aTuros, Edward | |
773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 179 _gp. 389-403 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2019.06.036 _zAvailable from publisher's website |
999 |
_c29857278 _d29857278 |